Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of how oligonucleotides function within living organisms is still rather limited. A major concern in this regard is the mechanisms of cellular uptake and intracellular trafficking of both 'free' oligonucleotides and oligonucleotides associated with various polymeric or nanocarrier delivery systems. Here we review basic aspects of the mechanisms of endocytosis and intracellular trafficking and how insights from these processes can be used to understand oligonucleotide delivery. In particular we discuss opportunities for escape of oligonucleotides from endomembrane compartments and describe recent studies using small molecules to enhance oligonucleo...
Synthetic oligonucleotides offer interesting perspectives for the regulation of gene expression in n...
For more than two decades, antisense oligonucleotides (ODNs) have been used to modulate gene express...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...
Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of ho...
One of the major constraints on the therapeutic use of oligonucleotides is inefficient delivery to t...
Significant progress is being made concerning the development of oligonucleotides as therapeutic age...
The problem of targeted delivery of antisense and siRNA oligonucleotides can be resolved into two di...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the...
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great...
The therapeutic use of antisense and siRNA oligonucleotides has been constrained by the limited abil...
Oligonucleotides are promising drug candidates due to the exceptionally high specificity they exhibi...
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list o...
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list o...
The unravelling of the human genome together with proteomic and genomic databases of specific disea...
Synthetic oligonucleotides offer interesting perspectives for the regulation of gene expression in n...
For more than two decades, antisense oligonucleotides (ODNs) have been used to modulate gene express...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...
Oligonucleotides manifest much promise as potential therapeutic agents. However, understanding of ho...
One of the major constraints on the therapeutic use of oligonucleotides is inefficient delivery to t...
Significant progress is being made concerning the development of oligonucleotides as therapeutic age...
The problem of targeted delivery of antisense and siRNA oligonucleotides can be resolved into two di...
There is mounting interest in developing antisense and siRNA oligonucleotides into therapeutic entit...
The oligonucleotide therapeutics field has seen remarkable progress over the last few years with the...
The potential use of antisense and siRNA oligonucleotides as therapeutic agents has elicited a great...
The therapeutic use of antisense and siRNA oligonucleotides has been constrained by the limited abil...
Oligonucleotides are promising drug candidates due to the exceptionally high specificity they exhibi...
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list o...
Oligonucleotides (ONs) comprise a rapidly growing class of therapeutics. In recent years, the list o...
The unravelling of the human genome together with proteomic and genomic databases of specific disea...
Synthetic oligonucleotides offer interesting perspectives for the regulation of gene expression in n...
For more than two decades, antisense oligonucleotides (ODNs) have been used to modulate gene express...
Attaining the full therapeutic utility of antisense and siRNA oligonucleotides will require understa...